112 related articles for article (PubMed ID: 10557592)
1. New vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), and varicella (chickenpox) vaccines, and revised vaccine information materials for measles, mumps, rubella (MMR) vaccines. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice.
Fed Regist; 1999 Feb; 64(35):9042-8. PubMed ID: 10557592
[TBL] [Abstract][Full Text] [Related]
2. Proposed vaccine information materials for hepatitis B, Haemophilus influenzae type b (Hib), Varicella (chickenpox), and measles, mumps, rubella (MMR) vaccines--CDC. Notice with comment period.
Fed Regist; 1998 Sep; 63(171):47026-31. PubMed ID: 10182707
[TBL] [Abstract][Full Text] [Related]
3. Revised diphtheria, tetanus, and pertussis (DTP/DTaP/DT) vaccine information materials--CDC. Notice.
Fed Regist; 1998 Jan; 63(6):1730-3. PubMed ID: 10177063
[TBL] [Abstract][Full Text] [Related]
4. Interim polio vaccine information materials. Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. Notice.
Fed Regist; 1999 Feb; 64(35):9040-2. PubMed ID: 10557593
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
[TBL] [Abstract][Full Text] [Related]
7. Progress in timely vaccination coverage among children living in low-income households.
Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
[TBL] [Abstract][Full Text] [Related]
8. Continued shortage of Haemophilus influenzae Type b (Hib) conjugate vaccines and potential implications for Hib surveillance--United States, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Nov; 57(46):1252-5. PubMed ID: 19023262
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
[TBL] [Abstract][Full Text] [Related]
10. Update on universal childhood immunizations.
Hamlin J; Senthilnathan S; Bernstein HH
Curr Opin Pediatr; 2008 Aug; 20(4):483-9. PubMed ID: 18622208
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
Vesikari T; Baer M; Willems P
Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
[TBL] [Abstract][Full Text] [Related]
12. Educating teens about vaccines.
Hernandez G; Nestor C
J Pediatr Health Care; 2006; 20(5):342-9. PubMed ID: 16962442
[No Abstract] [Full Text] [Related]
13. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
14. Combination vaccines.
Chokephaibulkit K
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S694-9. PubMed ID: 12403249
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
[TBL] [Abstract][Full Text] [Related]
17. Trends in early childhood vaccination coverage: progress towards US Healthy People 2010 goals.
Zhao Z; Smith PJ; Luman ET
Vaccine; 2009 Aug; 27(36):5008-12. PubMed ID: 19524616
[TBL] [Abstract][Full Text] [Related]
18. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
19. Report from the CDC. Vaccines in women.
Schmidt JV; Kroger AT; Roy SL
J Womens Health (Larchmt); 2004 Apr; 13(3):249-57. PubMed ID: 15130253
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
Goh P; Lim FS; Han HH; Willems P
Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
